SCHEMBL23275907

SCHEMBL23275907

Cc1cc(C(=O)O)ccc1-c1ccnc(Nc2cnn(C)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 1/20 0.49
▸ CDK2 P24941 1/20 0.49
▸ GSK3B P49841 1/20 0.49
▸ CCNT1 O60563 1/20 0.48
▸ CDK9 P50750 1/20 0.48
▸ BTK Q06187 11/20 0.47
▸ JAK2 O60674 5/20 0.46
▸ JAK1 P23458 4/20 0.46
▸ TYK2 P29597 4/20 0.46
▸ STAT3 P40763 1/20 0.46
▸ JAK3 P52333 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ HRH2 P25021 1/20 0.46
▸ CDK7 P50613 1/20 0.46
▸ CD69 Q07108 1/20 0.46
▸ AAK1 Q2M2I8 1/20 0.46
▸ MAP3K19 Q56UN5 1/20 0.46
▸ CDKL2 Q92772 1/20 0.46
▸ RIOK1 Q9BRS2 1/20 0.46
▸ RIOK2 Q9BVS4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29901235 1.00 CDK4 (0.49) CDK4CDK2GSK3BCCNT1CDK9
SCHEMBL23281912 0.90 ABL1 (0.49) CCNT1CDK9BTKJAK2JAK1
SCHEMBL22097648 0.89 CCNT1 (0.52) CDK4CDK2GSK3BCCNT1CDK9
SCHEMBL23275697 0.85 JAK2 (0.52) CDK2CDK9BTKJAK2JAK1
SCHEMBL23275806 0.84 JAK2 (0.52) BTKJAK2JAK1TYK2JAK3
SCHEMBL23275696 0.84 CAMK2D (0.66) CDK4CDK2GSK3BBTKJAK2
SCHEMBL23275854 0.83 KDM4C (0.39) CDK4CDK2GSK3BBTKJAK2
SCHEMBL23275833 0.83 JAK2 (0.49) CDK4CDK2GSK3BCDK9BTK
SCHEMBL23275876 0.82 BTK (0.49) BTKJAK2JAK1TYK2STAT3
SCHEMBL23275856 0.81 BTK (0.59) BTKJAK2JAK1TYK2STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174648-A1 Small Molecule Compound TECHNODERMA MEDICINES INC. (CN) 2024-05-30 — — US disclosed
WO-2021078023-A1 SMALL MOLECULE COMPOUND 嘉兴特科罗生物科技有限公司 2021-04-29 — — WO disclosed
WO-2021078023-A1 SMALL MOLECULE COMPOUND 嘉兴特科罗生物科技有限公司 2021-04-29 — — WO disclosed
CN-110627775-A Small molecule compound 嘉兴特科罗生物科技有限公司 2019-12-31 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174648-A1 Small Molecule Compound JAK1, JAK2, TYK2 CDK4 171/4885CDK2 15/4885GSK3B 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback